Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us

Marie Beaufrère, Bilade Cherqaoui and Félicie Costantino
The Journal of Rheumatology October 2025, 52 (10) 961-963; DOI: https://doi.org/10.3899/jrheum.2025-0809
Marie Beaufrère
1M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marie Beaufrère
Bilade Cherqaoui
2B. Cherqaoui, MD, PhD, Pediatrics Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, France, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bilade Cherqaoui
Félicie Costantino
1M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Félicie Costantino
  • For correspondence: felicie.costantino{at}aphp.fr
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 52 no. 10 961-963
DOI 
https://doi.org/10.3899/jrheum.2025-0809
PubMed 
40890013

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online October 1, 2025.

Article Versions

  • Latest version (September 1, 2025 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2025 by the Journal of Rheumatology

Author Information

  1. Marie Beaufrère1,
  2. Bilade Cherqaoui2 and
  3. Félicie Costantino1⇑
  1. 1M. Beaufrère, MD, PhD, F. Costantino, MD, PhD, Rheumatology Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux;
  2. 2B. Cherqaoui, MD, PhD, Pediatrics Department, AP-HP, Ambroise Paré Hospital, Boulogne-Billancourt, France, and Université Paris-Saclay, UVSQ, INSERM UMR1173, Infection & Inflammation, Laboratory of Excellence INFIBREX, Montigny-Le-Bretonneux, France.
  1. Address correspondence to Dr. F. Costantino, Hôpital Ambroise Paré, 9 Avenue Charles de Gaulle, 92104 Boulogne-Billancourt Cedex, France. Email: felicie.costantino{at}aphp.fr.

Article usage

Article usage: August 2025 to October 2025

AbstractFullPdf
Aug 2025405
Sep 20253112126
Oct 20255611030253

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology: 52 (10)
The Journal of Rheumatology
Vol. 52, Issue 10
1 Oct 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us
Marie Beaufrère, Bilade Cherqaoui, Félicie Costantino
The Journal of Rheumatology Oct 2025, 52 (10) 961-963; DOI: 10.3899/jrheum.2025-0809

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Rethinking HLA-B27 Testing: What HLA-B27 Can—and Cannot—Tell Us
Marie Beaufrère, Bilade Cherqaoui, Félicie Costantino
The Journal of Rheumatology Oct 2025, 52 (10) 961-963; DOI: 10.3899/jrheum.2025-0809
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • HLA-B27: a cornerstone in spondyloarthritis
    • Lessons learned from HLA-B27 referral patterns
    • HLA-B27 testing in clinical practice: when, how, and what next?
    • How to improve HLA-B27 use in clinical practice
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Confidence in the Use of Immunomodulatory Medications During Pregnancy: How Can Patient and Clinician Experience Be Improved?
  • Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action
  • Ample Room for Improvement
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire